Literature DB >> 3964994

The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study.

R J Glynn, E W Campion, G R Bouchard, J E Silbert.   

Abstract

This study describes the development of benign prostatic hyperplasia among 2,036 volunteers in the Veterans Administration Normative Aging Study, a longitudinal study of human aging situated in Boston. Men were followed from enrollment in the study (between 1961 and 1970) until their last examination prior to May 15, 1982. Two indications of benign prostatic hyperplasia were considered: 1) a clinical diagnosis made at a uniform physical examination, and 2) surgical treatment. Incidence rates for both a clinical diagnosis and surgery for benign prostatic hyperplasia increased through the eighth decade. Life table analysis estimated the lifetime probability of surgical treatment to be 0.29. Known risk factors for cardiovascular disease and diabetes as well as marital and socioeconomic status, religion, cigarette smoking and alcohol and coffee consumption were evaluated as risk factors. Controlling for age in proportional hazards models, statistically significant predictors of surgery were prior clinical diagnosis, lower socioeconomic status, Jewish religion, and not currently smoking cigarettes; whereas only body mass index was a significant predictor of a clinical diagnosis. Although a prior clinical diagnosis was an important predictor of surgery (adjusted odds ratio 3.52, 95% confidence interval = 1.93-6.42), this diagnosis is neither sensitive nor specific in its association with surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964994

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  57 in total

Review 1.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

2.  Postoperative urinary retention in men.

Authors:  P H O'Reilly
Journal:  BMJ       Date:  1991-04-13

3.  Irreversible renal failure in men with outflow obstruction: is it a preventable disease?

Authors:  D E Neal
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

4.  Sexual Function and alpha-Blockers.

Authors:  Kevin T McVary
Journal:  Rev Urol       Date:  2005

5.  Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.

Authors:  D Giri; M Ittmann
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

6.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

7.  Persistent detrusor overactivity after transurethral resection of the prostate.

Authors:  Fadi Housami; Paul Abrams
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

8.  Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.

Authors:  A S Bdesha; C J Bunce; J P Kelleher; M E Snell; J Vukusic; R O Witherow
Journal:  BMJ       Date:  1993-05-15

9.  The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.

Authors:  Paz Vital; Patricia Castro; Susan Tsang; Michael Ittmann
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

10.  Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunction.

Authors:  Anna P Malykhina; Qi Lei; Shaohua Chang; Xiao-Qing Pan; Antonio N Villamor; Ariana L Smith; Allen D Seftel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.